News and Trends 8 Jan 2018
Biotech in London Paves the Way for a New Therapy for Ulcerative Colitis
…trial run by London-based biotech TopiVert have shown potential for a new type of therapy for ulcerative colitis. The study revealed that the drug, called TOP1288, was safe and had…